Pharmafile Logo

Kraeber (UK) Ltd

The family owned business, Kraeber & Co GmbH, is an independent, technology based enterprise which was founded on the 1st January 1980 in Hamburg. Hanseatic tradition together with courageous entrepreneurship characterize our company. We are committed to open and global competition which we stand up with our service capabilities. Our emphasis is the development, production, marketing and sales of active pharmaceutical ingredients (APIs) of the highest purity. Kraeber has evolved into a niche marketer and supplier. By continously innovating productions, we became the quality market leader in Europe and in other parts of the world for many of our products.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

No items found

Company Details

16 The Street, Saxon Street, Newmarket, Suffolk, CB8 9RU, United Kingdom
+44 (0)1638 731 297

 Latest Content from PMHub 

Missed Origins’ Webinar? Watch How Patient Experience Data is Changing Pharma!

We are thrilled to announce that the recording of our recent webinar, "Patient Data: From data to decisions, maximising the impact of patience experience data in pharma" is now available...

New report now available: Integrating ‘patient first’ into medicine development

A new report has just been published by Cuttsy+Cuttsy that collates all the current best thinking in the ‘patient first’ space, distilling it into a practical and actionable road map...

Always Be in a Growth Mindset: Chief Strategy Officer Christina Hoffman’s Return to Her Education Roots

Medicine is always changing, and the career of Medscape Education’s Chief Strategy Officer, Christina Hoffman, is no exception. The 17-year Medscape veteran recently said goodbye to her role as leader...

Overcoming Collaboration Barriers – Perks of Virtual Medical Education

Explore the advantages of virtual collaboration in minimizing production blocking and cognitive interference! Our new video from the "Perks of Virtual Medical Education" series shows how electronic brainstorming can outperform...

The digital prescription – enhancing the patient experience with technology

We explore how digital health innovations are revolutionising patient care by enhancing accessibility, personalisation, and engagement, promising a more connected and empowered patient experience.

The key to HCP engagement: 5 Tips for pharma marketers

Did you know that in 2023 in the US, the pharma industry spent approximately USD 15.84 billion on digital advertising? The US healthcare industry is expected to grow to 29.2...

Say Wins Communiqué Agility, Flexibility And Transformation Award For Corporate Comms During Geopolitical Upheaval

SAY took home the Agility, Flexibility and Transformation Award at the prestigious Communiqué Awards on 4 July 2024 in recognition of the communications support provided The Royal College of Occupational...

Compliance — a driving force for influencing public perceptions of the pharma industry?

How does compliance play into public perceptions of pharma and why is it important for improving public opinion?

Oxford PharmaGenesis welcomes Christopher Rains on board as our first Non-Executive Director

Oxford PharmaGenesis is proud to announce the appointment of Christopher Rains as our first Non-Executive Director, strengthening the Board with over 30 years of experience in the pharmaceutical industry. A...